Literature DB >> 21183604

A case of pulmonary aspergilloma and actinomycosis.

Chen-Wei Huang1, Ming-An Lee1, Ruey-Hwa Lu2, Hui-Chin Peng3, Heng-Shen Chao4.   

Abstract

Pulmonary aspergilloma and pulmonary actinomycosis are rare pulmonary infectious diseases. Clinical manifestations of pulmonary aspergilloma and pulmonary actinomycosis include chronic cough, fever, chest pain, haemoptysis and other pathologies, but some patients may be asymptomatic. We report a case of a healthy 33-year-old woman without any underlying diseases, who was admitted to Zhongxing Branch of Taipei City Hospital, Taiwan, for intermittent haemoptysis and right upper chest pain, which had persisted for several months. A chest radiograph revealed a focal consolidation in the right upper lobe (RUL) of the lung, which grew in size over time. A sputum study and bronchoscopy revealed no positive findings, although malignancy could not be ruled out. Thus, the patient received a wedge resection of the RUL lesion. Subsequent, pathological examination demonstrated the presence of pulmonary aspergilloma and pulmonary actinomycosis. The patient's symptoms resolved after resection of the RUL lesion.

Entities:  

Mesh:

Year:  2010        PMID: 21183604     DOI: 10.1099/jmm.0.026427-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  3 in total

1.  A rare coexistence of aspergillosis with actinomycosis.

Authors:  B Hari Vinay; Aditya Mohan; P Haritha; K Roja Lakshmi
Journal:  J Oral Maxillofac Pathol       Date:  2017 May-Aug

Review 2.  Pulmonary Actinomycosis Mimicking Pulmonary Aspergilloma and a Brief Review of the Literature.

Authors:  Yoshitsugu Higashi; Shigeki Nakamura; Nobuyuki Ashizawa; Kazuhiro Oshima; Akitaka Tanaka; Taiga Miyazaki; Koichi Izumikawa; Katsunori Yanagihara; Yoshihiro Yamamoto; Yoshitsugu Miyazaki; Hiroshi Mukae; Shigeru Kohno
Journal:  Intern Med       Date:  2017-02-15       Impact factor: 1.271

3.  Successful treatment of liver aspergilloma by caspofungin acetate first-line therapy in a non-immunocompromised patient.

Authors:  Qing-Xian Bai; Yi Huan; Jian-Hong Wang; Li-Jie Yang; Hong-Juan Dong
Journal:  Int J Mol Sci       Date:  2012-09-06       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.